Skip to main content
Clinical Trials/NL-OMON54561
NL-OMON54561RecruitingPhase 3

PeRcutaneous cOronary intervention of native Coronary arTery versus venous bypass graft in patients with prior cORonary artery bypass graft surgery - the PROCTOR trial - PROCTOR trial

Vrije Universiteit Medisch Centrum0 sites240 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
240

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • 1. A significant stenosis (>50% on angiography) in a venous bypass graft
  • 2. Clinical indication for revascularization as determined by the local heart
  • team (based on symptoms, documented ischemia, and viability)
  • 3. Both the native coronary artery lesion(s) and the sapheneous vein graft
  • lesion(s) must be deemed technically feasible for PCI by the Heart Team.

Exclusion Criteria

  • < 18 years of age
  • Target vessel diameter < 2.5 mm
  • Graft diameter > 5.5 mm
  • CABG performed less than 1 year prior to inclusion
  • Aneurysm formation in the bypass graft
  • Heavy burden of thrombus in the bypass graft (>50% of the bypass graft lumen
  • in >=2 out of 3 of the proximal, middle or distal third of the bypass graft).
  • STEMI at presentation
  • NSTEMI patients with ongoing ischemia
  • Cardiogenic shock
  • Pregnancy
  • Estimated life expectancy < 3 year
  • Failure to provide informed consent

Investigators

Similar Trials